全文获取类型
收费全文 | 946篇 |
免费 | 79篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 48篇 |
妇产科学 | 23篇 |
基础医学 | 143篇 |
口腔科学 | 63篇 |
临床医学 | 97篇 |
内科学 | 144篇 |
皮肤病学 | 7篇 |
神经病学 | 156篇 |
特种医学 | 15篇 |
外科学 | 66篇 |
综合类 | 3篇 |
预防医学 | 139篇 |
眼科学 | 11篇 |
药学 | 63篇 |
肿瘤学 | 37篇 |
出版年
2024年 | 1篇 |
2023年 | 8篇 |
2022年 | 13篇 |
2021年 | 15篇 |
2020年 | 21篇 |
2019年 | 23篇 |
2018年 | 31篇 |
2017年 | 23篇 |
2016年 | 30篇 |
2015年 | 34篇 |
2014年 | 38篇 |
2013年 | 41篇 |
2012年 | 89篇 |
2011年 | 81篇 |
2010年 | 47篇 |
2009年 | 40篇 |
2008年 | 77篇 |
2007年 | 71篇 |
2006年 | 53篇 |
2005年 | 62篇 |
2004年 | 60篇 |
2003年 | 62篇 |
2002年 | 42篇 |
2001年 | 7篇 |
2000年 | 7篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有1027条查询结果,搜索用时 140 毫秒
11.
12.
13.
Dimitra Zannidi Kalliopi Karatzi Eva Karaglani Stavros Liatis Greet Cardon Violeta Iotova Kaloyan Tsochev Nevyana Chakarova Luis A. Moreno Paloma Flores-Barrantes Sándorné Radó Imre Rurik Jaana Lindström Konstantinos Makrilakis Yannis Manios the FeelDiabetes Study Group 《Journal of human nutrition and dietetics》2023,36(1):62-74
14.
15.
Sundvall J Leiviskä J Alfthan G Vartiainen E 《Clinica chimica acta; international journal of clinical chemistry》2007,378(1-2):93-98
BACKGROUND: The aim was to assess which factors cause a systematic error in serum total cholesterol measurements and how bias can influence the interpretation of serum cholesterol changes of the Finnish population. METHODS: Data on precision and accuracy during 27 years for serum total cholesterol were documented from participation in 438 rounds of five different external quality assessment (EQA) programs. RESULTS: The mean annual accuracy (bias) of the cholesterol assay using the results from all EQAs during 1978-2004 was -0.74% (95%CI -0.88 to -0.60). An exceptionally large deviation in bias coincided with the introduction of a new serum calibrator lot. New methods or instrumentation had only a minor impact on serum cholesterol bias. The mean serum cholesterol bias during the latest five population studies in 1982-2002 was -0.10% (95%CI -0.60 to 0.40) but comparison of the bias between the last study (CDC EQA in 2002) and the four previous ones (WHO EQA) showed a net difference of 3.32% (p<0.001). Correcting the mean serum cholesterol of men with respect to WHO and CDC EQA bias changed the interpretation for the last two survey years from an increase of 1.8% to no change. CONCLUSIONS: It is necessary to participate in EQA programs, which include target values measured by the CDC cholesterol reference method and then to perform bias corrections on the mean cholesterol values of the populations. 相似文献
16.
BACKGROUND: Copayments are common measures intended to control drug expenditures and promote rational prescribing. In Finland, new antiglaucoma drugs start with a high copayment, but once sufficient clinical experience is available, they are reevaluated and can receive a lower copayment status. OBJECTIVE: This study assessed the effect of changes in copayment level on the adoption of 2 antiglaucoma drugs. METHODS: A retrospective analysis was performed from 1997 to 2001 using the Finnish national register of reimbursed drug purchases, which covers approximately 98% of all antiglaucoma drug purchases in the country. There were 172,293 purchases of dorzolamide (plain or combined with timolol) and 281,377 purchases of latanoprost. An interrupted time-series design from approximately 30 months before and 20 months after the change in copayment was used in the analysis. The main outcome measures were the numbers of defined daily doses (DDDs) purchased and the monthly numbers of patients who purchased the study drugs for the first time before and after the change in copayment. RESULTS: A substantial increase in consumption of both dorzolamide and latanoprost was seen immediately after the introduction of the lower copayment. The monthly consumption of dorzolamide was 60,713 DDDs higher and the monthly consumption of latanoprost was 49,330 DDDs higher than expected according to the utilization trend during the higher copayment period. Twelve months later, the observed consumption of dorzolamide was 109% higher and that of latanoprost was 21% higher than if the copayment had remained the same. The number of new patients using the study drugs peaked within 2 months of the lower copayment, but the amount consumed per patient per day remained quite stable. CONCLUSIONS: Decreasing the copayment of a new antiglaucoma drug to the same level as the copayments of alternative drugs accelerated the adoption of these new products in Finland. 相似文献
17.
Sebastian Therman Jaana Suvisaari Christina M. Hultman 《International journal of methods in psychiatric research》2014,23(1):62-68
Full‐information factor analysis of ordinal data was employed to determine the factorial structure of the responses of 31,822 adult Swedish women to the 20 “positive” psychotic experience items of the Community Assessment of Psychic Experiences (CAPE) questionnaire. Five separable but correlated trait dimensions were found, reflecting Paranoia, Grandiosity, Magical Thinking, Delusions, and Hallucinations. High scores on any dimension were associated with a higher probability of questionnaire‐assessed lifetime major depressive episodes or generalized anxiety disorder, though Grandiosity was so only to a very small degree. Our results closely match previous findings among adolescents and young women, and demonstrate that psychotic experiences cannot be considered a single trait. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
18.
THE ROLE OF PSYCHIATRIC,CARDIOMETABOLIC, AND MUSCULOSKELETAL COMORBIDITY IN THE RECURRENCE OF DEPRESSION‐RELATED WORK DISABILITY 下载免费PDF全文
19.
Simoila Laura Isomets Erkki Gissler Mika Suvisaari Jaana Halmesmki Erja Lindberg Nina 《Archives of women's mental health》2020,23(1):91-100
Archives of Women's Mental Health - To assess psychosocial and somatic risk factors related to pregnancy, and pregnancy-related complications or disorders in women with schizophrenia compared... 相似文献
20.
Marja A. Tölli Mónica P.A. Ferreira Sini M. Kinnunen Jaana Rysä Ermei M. Mäkilä Zoltán Szabó Raisa E. Serpi Pauli J. Ohukainen Mika J. Välimäki Alexandra M.R. Correia Jarno J. Salonen Jouni T. Hirvonen Heikki J. Ruskoaho Hélder A. Santos 《Biomaterials》2014
Myocardial infarction (MI), commonly known as a heart attack, is the irreversible necrosis of heart muscle secondary to prolonged ischemia, which is an increasing problem in terms of morbidity, mortality and healthcare costs worldwide. Along with the idea to develop nanocarriers that efficiently deliver therapeutic agents to target the heart, in this study, we aimed to test the in vivo biocompatibility of different sizes of thermally hydrocarbonized porous silicon (THCPSi) microparticles and thermally oxidized porous silicon (TOPSi) micro and nanoparticles in the heart tissue. Despite the absence or low cytotoxicity, both particle types showed good in vivo biocompatibility, with no influence on hematological parameters and no considerable changes in cardiac function before and after MI. The local injection of THCPSi microparticles into the myocardium led to significant higher activation of inflammatory cytokine and fibrosis promoting genes compared to TOPSi micro and nanoparticles; however, both particles showed no significant effect on myocardial fibrosis at one week post-injection. Our results suggest that THCPSi and TOPSi micro and nanoparticles could be applied for cardiac delivery of therapeutic agents in the future, and the PSi biomaterials might serve as a promising platform for the specific treatment of heart diseases. 相似文献